RedHill Biopharma (RDHL) Asset Utilization Ratio (2016 - 2023)
Historic Asset Utilization Ratio for RedHill Biopharma (RDHL) over the last 12 years, with Q4 2024 value amounting to 0.09.
- RedHill Biopharma's Asset Utilization Ratio fell 8568.89% to 0.09 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.09, marking a year-over-year decrease of 8568.89%. This contributed to the annual value of 391482.11 for FY2024, which is 54530810404.32% up from last year.
- Latest data reveals that RedHill Biopharma reported Asset Utilization Ratio of 0.09 as of Q4 2024, which was down 8568.89% from 0.24 recorded in Q2 2024.
- In the past 5 years, RedHill Biopharma's Asset Utilization Ratio registered a high of 0.76 during Q2 2023, and its lowest value of 0.05 during Q1 2020.
- Its 5-year average for Asset Utilization Ratio is 0.38, with a median of 0.42 in 2021.
- Per our database at Business Quant, RedHill Biopharma's Asset Utilization Ratio skyrocketed by 71254.45% in 2021 and then crashed by 8568.89% in 2024.
- Over the past 5 years, RedHill Biopharma's Asset Utilization Ratio (Quarter) stood at 0.37 in 2020, then grew by 26.61% to 0.47 in 2021, then decreased by 16.2% to 0.39 in 2022, then soared by 60.19% to 0.63 in 2023, then tumbled by 85.69% to 0.09 in 2024.
- Its last three reported values are 0.09 in Q4 2024, 0.24 for Q2 2024, and 0.63 during Q4 2023.